首页> 美国卫生研究院文献>Internal Medicine >Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the 18F-FDG PET/CT Findings
【2h】

Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the 18F-FDG PET/CT Findings

机译:肝内胆管细胞和胆管细胞癌-18F-FDG PET / CT结果的差异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cholangiolocellular carcinoma is a minor primary cancerous tumor of the liver and its coexistence with intrahepatic cholangiocarcinoma in the liver is rare. We herein report a case of concurrent cholangiolocellular carcinoma and intrahepatic cholangiocarcinoma in the liver, in addition to a rectal G1 neuroendocrine tumor, a so-called carcinoid. The intrahepatic tumors showed a different uptake in the 18F-fluoro-2-deoxyglucose (FDG) positron-emission tomography (PET)/computed tomography (CT) findings. In addition to conventional dynamic contrast-enhanced CT, we concluded that FDG PET/CT could therefore be a helpful modality to identify the properties of both cholangiolocellular carcinoma and intrahepatic cholangiocarcinoma.
机译:胆管细胞癌是一种较小的原发性肝癌,很少与肝内胆管癌共存。我们在此报告了除了直肠G1神经内分泌肿瘤(所谓的类癌)外,还有肝脏并发胆管细胞癌和肝内胆管癌的病例。肝内肿瘤在 18 F-氟-2-脱氧葡萄糖(FDG)正电子发射断层扫描(PET)/计算机断层扫描(CT)发现中显示出不同的摄取。除了常规的动态对比增强CT之外,我们得出的结论是,FDG PET / CT因此可能是鉴别胆管细胞癌和肝内胆管癌的有用手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号